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Introduction
Ventilator-associated pneumonia (VAP) occurs greater
than 48 hours following endotracheal intubation and is
a clinical diagnosis with no gold standard diagnostic cri-
terion. The Clinical Pulmonary Infection Score (CPIS) is
a tool used to aid diagnosis and comprises a clinical
score of 0-12 based on 6 variables: body temperature,
leukocyte count, volume and character of tracheal secre-
tions, arterial oxygenation, chest radiograph findings
and results of culture of tracheal aspirates. A score of ≥ 6
has been shown to correlate with the presence of VAP
with high sensitivity although low specificity [1].
Objectives
The aim of this audit was to use the CPIS to screen all
patients ventilated in our institution over the past five
years for VAP and look at trends in VAP rates over
time. We also reviewed all patients diagnosed with VAP
to assess causative organisms, antibiotic treatments and
admission specialty.
Methods
We used our electronic patient records to generate a
CPIS comprising temperature, white blood cell count,
tracheal secretions, microbiology results and PaO2/FiO2
ratio for each patient ventilator day from September
2009-August 2014. Any patient with an admission diag-
nosis of pneumonia was excluded. Any patient with a
CPIS ≥ 4 after the first 48 hours of ventilation had their
chest radiographs reviewed and scored. Patients with a
score of ≥ 6 then had their electronic patient record
reviewed to identify a diagnosis of either VAP or other
condition.
Results
There were 118 potential episodes of VAP identified
using a CPIS ≥ 6 in patients admitted over a five year
period. Review of the clinical records demonstrated 64
episodes of VAP and 54 episodes where another source
of sepsis or indication for antibiotic therapy was identi-
fied. This correlates with a specificity of 54%.
Figure 1 shows a reduction in VAP rate over time.
Of all patients diagnosed with VAP there were a high
percentage from certain specialties: Trauma 27%,
Cardiac 18% and Vascular 17% of patients. The relative
percentage of patients admitted from these specialties to
our ICU in this period was 5%, 6% and 4% respectively.
Figure 2 shows the sputum culture results over time
and that peak VAP rates correlate with negative
cultures.
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Figure 1 VAP rate over time.
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Figure 3 shows the relative usage of antibiotics. The
majority of patients received Tazocin (Piperacillin and
Tazobactam).
Conclusions
The specificity of the use of a CPIS ≥ 6 in the identifica-
tion of VAP of 54 % in our audit is similar to that pre-
viously described [1]. VAP rates have reduced over time
and peaks may be due to over diagnosis. The organisms
identified were sensitive to the antibiotics initiated given
local resistance patterns. Patient with preceding collapse
were more likely to be diagnosed with VAP.
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Figure 2 Tracheal aspirate results over time.
Figure 3 Antibiotic treatment of VAP.
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